Synthetic mRNA cap analogs with a modified triphosphate bridge – synthesis, applications and prospects

No abstract is available for this paper.

• Publication year

  2010

• Venue

  New Journal of Chemistry

• Publication date

  2010-05-01

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1039/C0NJ00041H
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications.

  2010cited by this paper
• Synthesis of Boranoate, Selenoate, and Thioate Analogs of AZTp(4)A and Ap(4)A.

  2009cited by this paper
• Drosophila miR2 primarily targets the m7GpppN cap structure for translational repression.

  2009cited by this paper
• Current prospects for mRNA gene delivery.

  2009cited by this paper
• Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation.

  2009cited by this paper
• Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization.

  2009cited by this paper
• Synthetic dinucleotide mRNA cap analogs with tetraphosphate 5',5' bridge containing methylenebis(phosphonate) modification.

  2009cited by this paper
• Synthesis of nucleoside Di- and triphosphates and dinucleoside polyphosphates with cycloSal-nucleotides.

  2009cited by this paper
• eIF4E: New Family Members, New Binding Partners, New Roles*

  2009cited by this paper
• Phosphoroselenoate Dinucleotides for Modification of mRNA 5′ End

  2009cited by this paper
• Identification of the HIT-45 protein from Trypanosoma brucei as an FHIT protein/dinucleoside triphosphatase: substrate specificity studies on the recombinant and endogenous proteins.

  2009cited by this paper
• mRNA decapping is promoted by an RNA-binding channel in Dcp2.

  2008cited by this paper
• Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.

  2008cited by this paper
• DcpS as a therapeutic target for spinal muscular atrophy.

  2008cited by this paper
• Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS.

  2008cited by this paper
• 1,3,2-Oxathiaphospholane approach to the synthesis of P-chiral stereodefined analogs of oligonucleotides and biologically relevant nucleoside polyphosphates

  2008cited by this paper
• Recent Developments in 5‘-Terminal Cap Analogs: Synthesis and Biological Ramifications.

  2008cited by this paper
• Synthesis and application of a new 2',3'-isopropylidene guanosine substituted cap analog.

  2008cited by this paper
• Synthesis and application of 2'-fluoro-substituted cap analogs.

  2007cited by this paper
• Weak binding affinity of human 4EHP for mRNA cap analogs.

  2007cited by this paper
• A simple and rapid synthesis of nucleotide analogues containing a phosphorothioate moiety at the terminal position of the phosphate chain

  2007cited by this paper
• Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.

  2007cited by this paper
• MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F

  2007cited by this paper
• Affinity of Dinucleotide Cap Analogues for Human Decapping Scavenger (hDcpS)

  2007cited by this paper
• mRNA-based gene transfer as a tool for gene and cell therapy.

  2007cited by this paper
• Messenger RNA decay in mammalian cells

  2007cited by this paper
• Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.

  2007cited by this paper
• Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells.

  2007cited by this paper
• Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability.

  2007cited by this paper
• Enzymatically stable 5' mRNA cap analogs: synthesis and binding studies with human DcpS decapping enzyme.

  2006cited by this paper
• Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

  2006cited by this paper
• mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level.

  2006cited by this paper
• Differential Inhibition of mRNA Degradation Pathways by Novel Cap Analogs*

  2006cited by this paper
• SYNTHESIS AND ENZYMATIC CHARACTERIZATION OF METHYLENE ANALOGS OF ADENOSINE 5′-TETRAPHOSPHATE (P4A)

  2005cited by this paper
• A direct method for the synthesis of nucleoside 5′-methylenebis(phosphonate)s from nucleosides

  2005cited by this paper
• Regulation of cap-dependent translation by eIF4E inhibitory proteins

  2005cited by this paper
• Preparation and Properties of mRNA 5-cap Structure

  2005cited by this paper
• Specificity of recognition of mRNA 5' cap by human nuclear cap-binding complex.

  2005cited by this paper
• SYNTHESIS AND BIOCHEMICAL PROPERTIES OF NOVEL mRNA 5′ CAP ANALOGS RESISTANT TO ENZYMATIC HYDROLYSIS

  2005cited by this paper
• Viral and cellular mRNA capping: Past and prospects

  2004cited by this paper
• Insights into the structure, mechanism, and regulation of scavenger mRNA decapping activity.

  2004cited by this paper
• Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

  2004cited by this paper
• Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5' terminus.

  2004cited by this paper
• Functional analysis of mRNA scavenger decapping enzymes.

  2004cited by this paper
• eIF-4E expression and its role in malignancies and metastases

  2004cited by this paper
• Novel "anti-reverse" cap analogs with superior translational properties.

  2003cited by this paper
• Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures

  2002cited by this paper
• Synthesis and application of a chain-terminating dinucleotide mRNA cap analog.

  2002cited by this paper
• The hDcp2 protein is a mammalian mRNA decapping enzyme

  2002cited by this paper
• Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.

  2002cited by this paper
• The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases

  2002cited by this paper
• Crystal structures of 7-methylguanosine 5'-triphosphate (m(7)GTP)- and P(1)-7-methylguanosine-P(3)-adenosine-5',5'-triphosphate (m(7)GpppA)-bound human full-length eukaryotic initiation factor 4E: biological importance of the C-terminal flexible region.

  2002cited by this paper
• Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-O-methyl)GpppG and 7-methyl (3'-deoxy)GpppG.

  2001cited by this paper
• Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20.

  2001cited by this paper
• RNA-transfected dendritic cells in cancer immunotherapy.

  2000cited by this paper
• Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E.

  2000cited by this paper
• Syntheses of nucleoside triphosphates.

  2000cited by this paper
• Quantitative assessment of mRNA cap analogues as inhibitors of in vitro translation.

  1999cited by this paper
• Synthesis and Reactions of Nucleoside 5‘-Diphosphate Imidazolide. A Nonenzymatic Capping Agent for 5‘-Monophosphorylated Oligoribonucleotides in Aqueous Solution

  1999cited by this paper
• eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

  1999cited by this paper
• The role of the cap structure in RNA processing and nuclear export.

  1997cited by this paper
• Specific protein recognition of an mRNA cap through its alkylated base

  1997cited by this paper
• Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP.

  1997cited by this paper
• The exosome: a conserved eukaryotic RNA processing complex containing multiple 3'-->5' exoribonucleases.

  1997cited by this paper
• Efficient synthesis of γ-methyl-capped guanosine 5′-triphosphate as a 5′-terminal unique structure of U6 RNA via a new triphosphate bond formation involving activation of methyl phosphorimidazolidate using ZnCl2 as a catalyst in DMF under anhydrous conditions

  1997cited by this paper
• Reverse 5' caps in RNAs made in vitro by phage RNA polymerases.

  1995cited by this paper
• One-pot reaction for the synthesis of M7G5' pppG and M7G5' pppA by using an activatable bifunctional phosphorylating reagent

  1994cited by this paper
• A nuclear cap binding protein complex involved in pre-mRNA splicing.

  1994cited by this paper
• In vivo transcriptional pausing and cap formation on three Drosophila heat shock genes.

  1993cited by this paper
• A cap binding protein that may mediate nuclear export of RNA polymerase II-transcribed RNAs

  1992cited by this paper
• Facile synthesis of cap portion of messenger RNA by Mn(II) ion-catalyzed pyrophosphate formation in aqueous solution

  1991cited by this paper
• Synthesis of long, capped transcripts in vitro by SP6 and T7 RNA polymerases.

  1989cited by this paper
• Recognition of cap structure in splicing in vitro of mRNA precursors.

  1984cited by this paper
• Promoter-proximal pausing by RNA polymerase II in vitro: transcripts shorter than 20 nucleotides are not capped.

  1983cited by this paper
• Simple, efficient in vitro synthesis of capped RNA useful for direct expression of cloned eukaryotic genes.

  1982cited by this paper
• mRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Purification and physical properties.

  1978cited by this paper
• Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

  1975cited by this paper
• Synthesis of oligothymidylates and nucleoside cyclic phosphates by oxidation-reduction condensation.

  1972cited by this paper
• Phosphorylation by Oxidation-Reduction Condensation. Preparation of Active Phosphorylating Reagents

  1971cited by this paper
• A novel method for phosphorylation of nucleosides to 5'-nucleotides.

  1967cited by this paper
• CONVERSION OF MONO- AND OLIGODEOXYRIBONUCLEOTIDES TO 5-TRIPHOSPHATES.

  1965cited by this paper

• The 5′ Cap Epitranscriptome and Beyond: Natural and Engineered 5′ Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies

  2026cites this paper
• Synthesis, Incorporation, and Translation Properties of Threose Nucleic Acid Modified Trinucleotide Cap Analogs

  2025cites this paper
• Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization.

  2023cites this paper
• Application of Phosphoramidate ProTide Technology for the Synthesis of 5’‐mRNA Cap Analogs Modified on the Exocyclic Amine Group

  2023cites this paper
• Efficient chemical synthesis of N2 -modified guanosine derivatives: a versatile probes for mRNA labeling

  2023cites this paper
• mRNA-based cancer therapeutics

  2023cites this paper
• Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles.

  2023cites this paper
• Protocols for Efficient Chemical Synthesis of N2‐Modified Guanosine Phosphate Derivatives: Versatile Probes for mRNA Labeling

  2023cites this paper
• Click-iT trinucleotide cap analog: Synthesis, mRNA translation, and detection.

  2022cites this paper
• Solution‐Phase Chemical Synthesis of Modified RNA Dinucleotides

  2022cites this paper
• Recent Advances in Modified Cap Analogs: Synthesis, Biochemical Properties, and mRNA Based Vaccines

  2022cites this paper
• Efficient and Improved Solution-Phase Synthesis of Modified RNA Dinucleotides: Versatile Synthons in Cap 1 mRNA Therapeutics

  2022cites this paper
• mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies

  2021cites this paper
• Novel N7-Arylmethyl Substituted Dinucleotide mRNA 5′ cap Analogs: Synthesis and Evaluation as Modulators of Translation

  2021cites this paper
• Nucleophilic 18F-fluorination of phosphorofluoridates and phosphonofluoridic acids via imidazole-activated precursors

  2021cites this paper
• Cellular delivery of dinucleotides by conjugation with small molecules: targeting translation initiation for anticancer applications

  2021cites this paper
• Trinucleotide Cap Analogue Bearing a Locked Nucleic Acid Moiety: Synthesis, mRNA Modification, and Translation for Therapeutic Applications.

  2021cites this paper
• Ethylenediamine derivatives efficiently react with oxidized RNA 3′ ends providing access to mono and dually labelled RNA probes for enzymatic assays and in vivo translation

  2021cites this paper
• Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression

  2020cites this paper
• Functional and LC-MS/MS analysis of in vitro transcribed mRNAs carrying phosphorothioate or boranophosphate moieties reveal polyA tail modifications that prevent deadenylation without compromising protein expression

  2020cites this paper
• Biomedical applications of mRNA nanomedicine

  2018cites this paper
• mRNAs biotinylated within the 5′ cap and protected against decapping: new tools to capture RNA–protein complexes

  2018cites this paper
• mRNA therapeutics deliver a hopeful message

  2018cites this paper
• Applications of Phosphate Modification and Labeling to Study (m)RNA Caps

  2017cites this paper
• mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation

  2017cites this paper
• Amino-Functionalized 5' Cap Analogs as Tools for Site-Specific Sequence-Independent Labeling of mRNA.

  2017cites this paper
• Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential

  2016cites this paper
• Two-headed tetraphosphate cap analogs are inhibitors of the Dcp1/2 RNA decapping complex

  2016cites this paper
• A novel route for preparing 5′ cap mimics and capped RNAs: phosphate-modified cap analogues obtained via click chemistry

  2016cites this paper
• Clickable trimethylguanosine cap analogs modified within the triphosphate bridge: synthesis, conjugation to RNA and susceptibility to degradation

  2016cites this paper
• Solid‐Phase Synthesis of DNA and RNA 5′‐O‐Triphosphates Using cycloSal Chemistry

  2016cites this paper
• Design, synthesis and biological evaluation of dinucleotide mRNA cap analog containing propargyl moiety.

  2016cites this paper
• Synthetic Capped mRNAs for Cap-Specific Photo-Cross-Linking Experiments.

  2016cites this paper
• Synthetic mRNA with Superior Properties that Mimics the Intracellular Fates of Natural Histone mRNA.

  2016cites this paper
• Phosphate-modified analogues of m(7)GTP and m(7)Gppppm(7)G-Synthesis and biochemical properties.

  2015cites this paper
• Synthesis of fluorophosphate nucleotide analogues and their characterization as tools for ¹⁹F NMR studies.

  2015cites this paper
• Design and Facile Synthesis of New Dinucleotide Cap Analog Containing Both 2′ and 3′-OH Modification on M7Guanosine Moiety

  2015cites this paper
• mRNA Cap Modification through Carb­amate Chemistry: Synthesis of Amino- and Carboxy-Functionalised Cap Analogues Suitable for Labelling and Bioconjugation

  2015cites this paper
• Poly(ADP-Ribose)—A Unique Natural Polymer Structural Features, Biological Role and Approaches to the Chemical Synthesis

  2015cites this paper
• Efficient Automated Solid-Phase Synthesis of DNA and RNA 5'-Triphosphates.

  2015cites this paper
• Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.

  2015cites this paper
• How To Form a Phosphate Anhydride Linkage in Nucleotide Derivatives

  2015cites this paper
• Solid‐Phase Synthesis of Oligonucleotide 5′‐(α‐P‐Thio)triphosphates and 5′‐(α‐P‐Thio)(β,γ‐methylene)triphosphates

  2015cites this paper
• Towards novel efficient and stable nuclear import signals: synthesis and properties of trimethylguanosine cap analogs modified within the 5',5'-triphosphate bridge.

  2014cites this paper
• Cap analogs containing 6-thioguanosine--reagents for the synthesis of mRNAs selectively photo-crosslinkable with cap-binding biomolecules.

  2014cites this paper
• Current and Emerging Therapies Targeting Translation

  2014cites this paper
• Innovative Chemistry for Synthesis of Regular RNA, 5′-Triphosphate RNA, or 5′-Capped RNA

  2014cites this paper
• mRNA and snRNA Cap Analogs: Synthesis and Applications

  2014influential citation
• Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes

  2014influential citation
• Synthesis and evaluation of fluorescent cap analogues for mRNA labelling.

  2013cites this paper
• Automated parallel synthesis of 5'-triphosphate oligonucleotides and preparation of chemically modified 5'-triphosphate small interfering RNA.

  2013cites this paper
• Potential therapeutic applications of RNA cap analogs.

  2013cites this paper
• Synthesis and biological validation of N⁷-(4-chlorophenoxyethyl) substituted dinucleotide cap analogs for mRNA translation.

  2013cites this paper
• The synthesis of isopropylidene mRNA cap analogs modified with phosphorothioate moiety and their evaluation as promoters of mRNA translation.

  2013cites this paper
• Efficient and Rapid Synthesis of Nucleoside Diphosphate Sugars from Nucleoside Phosphorimidazolides

  2013cites this paper
• New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain.

  2013cites this paper
• Emerging therapeutics targeting mRNA translation.

  2012influential citation
• Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety--fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis.

  2012cites this paper
• Synthesis of 5' cap-0 and cap-1 RNAs using solid-phase chemistry coupled with enzymatic methylation by human (guanine-N⁷)-methyl transferase.

  2012cites this paper
• Eukaryotic initiation factor 4F: a vulnerability of tumor cells.

  2012cites this paper
• An efficient synthesis of highly functionalized dinucleotide cap analogs

  2012cites this paper
• Synthesis of nucleoside phosphosulfates.

  2012cites this paper
• Synthesis of N²-modified 7-methylguanosine 5'-monophosphates as nematode translation inhibitors.

  2012cites this paper
• Synthesis of biotin labelled cap analogue--incorporable into mRNA transcripts and promoting cap-dependent translation.

  2012cites this paper
• Phosphorothioate Nucleotides and Oligonucleotides – Recent Progress in Synthesis and Application

  2011cites this paper
• Targeting Translation Dependence in Cancer

  2011cites this paper
• Synthetic mRNA Cap Analogues with a Modified Triphosphate Bridge — Synthesis, Applications and Prospects

  2010cites this paper